DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 204547
» See Plans and Pricing
NDA 204547 describes AMMONIA N 13, which is a drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Hlth 414, Central Radiopharm, Decatur, Essential Isotopes, Feinstein, Gen Hosp, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Ucla Biomedical, Ucsf Rodiopharm, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Wisconsin, Wa Univ Sch Med, and Wi Medcl Cyclotron, and is included in twenty-nine NDAs. It is available from fifteen suppliers. Additional details are available on the AMMONIA N 13 profile page.
The generic ingredient in AMMONIA N 13 is ammonia n-13. There are two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ammonia n-13 profile page.
The generic ingredient in AMMONIA N 13 is ammonia n-13. There are two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ammonia n-13 profile page.
Summary for 204547
| Tradename: | AMMONIA N 13 |
| Applicant: | Precision Nuclear |
| Ingredient: | ammonia n-13 |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 3.75-260mCi/ML | ||||
| Approval Date: | Aug 14, 2015 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
